lonafarnib [clinicaltrials_resource:a2a1be07cd8091069c0f157ab485e373]
Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003956]SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00006351]SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00020774]Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer [clinicaltrials:NCT00068757]Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas [clinicaltrials:NCT00083096]
intervention [clinicaltrials_vocabulary:intervention]
lonafarnib [clinicaltrials_resource:a2a1be07cd8091069c0f157ab485e373]
Bio2RDF identifier
a2a1be07cd8091069c0f157ab485e373
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a2a1be07cd8091069c0f157ab485e373
intervention name [clinicaltrials_vocabulary:intervention-name]
lonafarnib
identifier
clinicaltrials_resource:a2a1be07cd8091069c0f157ab485e373
title
lonafarnib
@en
type
label
lonafarnib [clinicaltrials_resource:a2a1be07cd8091069c0f157ab485e373]
@en